06.01.2014 Views

Annual Report 2010 - Hannover Re

Annual Report 2010 - Hannover Re

Annual Report 2010 - Hannover Re

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

The rating agency Standard & Poor’s has awarded the company<br />

a rating of “A” (stable outlook), which is higher than that<br />

of the country of South Africa.<br />

Central and South America<br />

The markets in this region are served directly from <strong>Hannover</strong>,<br />

although our offices in Mexico City (for Central America) and<br />

Rio de Janeiro (for Brazil) are assigned an important service<br />

role.<br />

A groundbreaking development occurred in this regard in the<br />

first half of <strong>2010</strong> with the first-ever completion of a financing<br />

arrangement for the in-force portfolio of a mid-sized primary<br />

insurer in the local currency – a transaction that we executed<br />

in close cooperation with and with the explicit consent of the<br />

China Insurance <strong>Re</strong>gulatory Commission (CIRC). In the second<br />

half of the year we were able to close another transaction<br />

of this type and we anticipate further potential in the years<br />

ahead.<br />

Whereas in Central America we support a broad range of primary<br />

insurers first and foremost through services in the areas<br />

of underwriting and claims management, our focus in South<br />

America is on bancassurers. We moved forward with our strategic<br />

cooperation in Brazil with Malucelli <strong>Re</strong>.<br />

By carefully selecting our ceding companies we enlarged our<br />

business volume to EUR 131.4 million, after EUR 101.5 million<br />

in the previous year. Of this amount, roughly EUR 30 million<br />

was attributable to the markets of Central America (incl.<br />

Mexico) and EUR 102.1 million to South America (incl. Brazil).<br />

Profitability again proved to be highly satisfactory.<br />

Asia<br />

Within the <strong>Hannover</strong> Life <strong>Re</strong> network the major growth region<br />

of Asia is served by a number of branches and service<br />

offices of <strong>Hannover</strong> <strong>Re</strong>. In this context the life branches in<br />

Kuala Lumpur and Hong Kong take on regional coordination<br />

and service functions in addition to their own direct market<br />

responsibilities.<br />

Business in ASEAN markets – with a focus on Malaysia, Singapore,<br />

Thailand and Vietnam – is written in Kuala Lumpur,<br />

while our service office in Mumbai handles the Indian market<br />

and the strategic cooperation with GIC <strong>Re</strong>.<br />

For the region of South Asia/Southeast Asia we booked premium<br />

of EUR 21.4 million in the year under review; results<br />

were thoroughly gratifying.<br />

Business in East Asia is coordinated through our regional centre<br />

in Hong Kong, which also bears direct responsibility for<br />

the markets of Hong Kong, Macau and Taiwan. <strong>Re</strong>sponsibility<br />

for the Chinese and Korean markets rests with our branches<br />

in Shanghai and Seoul respectively, while the Japanese market<br />

is served by our Tokyo office.<br />

Total premiums from the East Asian region (Greater China,<br />

Korea and Japan) amounted to EUR 201.6 million, an increase<br />

of more than 60% compared to the previous year.<br />

Premium income for the entire Asian region thus surpassed<br />

the EUR 200 million mark for the first time to reach EUR 223.0<br />

million (EUR 147.2 million). Despite fierce competition, most<br />

notably in Korea and Hong Kong, the technical results were<br />

again quite satisfactory.<br />

Australia and New Zealand<br />

Both these markets are served by our Sydney-based subsidiary<br />

HLR Australasia, which we acquired in 1993. The company<br />

writes traditional risk-oriented business from Australia<br />

and New Zealand, with an emphasis on mortality and critical<br />

illness covers as well as disability annuity business.<br />

In addition, in the role of primary insurer, we assume the biometric<br />

risks of Australian funds for occupational retirement<br />

provision (superannuation funds) and cooperate with a major<br />

Australian direct sales organisation to offer a range of riskoriented<br />

products. We see both these activities as an important<br />

source of diversification.<br />

Although the Australian reinsurance market showed scarcely<br />

any growth potential, HLR Australasia succeeded in significantly<br />

expanding its business volume overall. Premium income<br />

rose to EUR 324.4 million after EUR 251.3 million in<br />

the previous year, due in part to the strength of the Australian<br />

dollar against the euro.<br />

The highly unsatisfactory biometric risk experience in some<br />

areas was largely cushioned by quota share retrocessions,<br />

leaving an attractive operating profit of EUR 23.7 million for<br />

the net retention. This was equivalent to an EBIT margin of<br />

15.4%.<br />

Management report<br />

Business in the entire East Asian region is growing at a very<br />

dynamic pace. Particularly in China, we were able to extend<br />

our position as one of the two leading foreign life reinsurers.<br />

<strong>Hannover</strong> <strong>Re</strong> Group annual report <strong>2010</strong><br />

Life and health reinsurance Management report<br />

45

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!